H1 2023 Financial Highlights

Conclusion Strategic roadmap driving growth story IPSEN Innovation for patient care Γ D DELIVERING FURTHER STRONG RESULTS ADVANCING PIPELINE Growth platforms & newly acquired medicines driving sales growth A strong core operating margin Cash generation supporting a robust balance sheet Several programs added to pipeline Favorable developments in first half of year Anticipated regulatory decisions in near term Capital-markets day: 7 December 2023, London L 21

View entire presentation